The NEDD8-activating enzyme E1 UBA3 orchestrates the immunosuppressive microenvironment in lung adenocarcinoma via the NF-?B pathway

被引:0
|
作者
Lin, Xiongzhi [1 ,2 ]
Yang, Shuhan [1 ,3 ]
Zhou, Caichuan [1 ,3 ]
Ao, Chengcheng [1 ,3 ]
Sun, Dongsheng [3 ]
机构
[1] Taizhou Univ, Taizhou Univ Hosp, Taizhou Cent Hosp, Taizhou, Zhejiang, Peoples R China
[2] Hebei North Univ, Grad Sch Med, Zhangjiakou, Hebei, Peoples R China
[3] Taizhou Univ, Med Sch, Taizhou, Zhejiang, Peoples R China
关键词
Lung adenocarcinoma; NEDD8-activating enzyme; UBA3; Nuclear factor kappa B; Immunosuppressive microenvironment; PLASMACYTOID DENDRITIC CELLS; TUMOR; PROGRESSION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immunosuppressive cells play important roles in generating an immunosuppressive tumor microenvironment and facilitating tumor immune escape. However, the molecular mechanisms underlying their immunosuppressive effects remain unclear. UBA3, the sole catalytic subunit of the neural precursor cell expressed developmentally down-regulated protein 8 (NEDD8)-activating enzyme E1, is highly expressed in various human malignancies, along with an activated neddylation pathway. In this study, we investigated the relationships between the UBA3-dependent neddylation pathway and the infiltration of several immunosuppressive cell populations in lung adenocarcinoma (LUAD). We explored the regulatory mechanisms of UBA3 in LUAD cells by using mRNA sequencing and functional enrichment analyses. Correlations between neddylation and immune infiltrates were assessed by Western blotting, real-time PCR, and analyses of public databases. We found elevated levels of UBA3 expression in LUAD tissues compared to adjacent normal tissues. Blocking UBA3 and the neddylation pathway promoted the accumulation of the phosphorylated nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor (p-I & kappa;B & alpha;), inhibiting the gene expression of tumor cell-derived cytokines such as C-C motif chemokine ligand (CCL) 2, C-X-C motif ligand (CXCL)1, CXCL2, colony-stimulating factor (CSF) 1, CSF2 interleukin (IL)-6, and IL-1B. Moreover, the overexpression of UBA3 in LUAD cells was associated with the secretion of these cytokines, and the recruitment and infiltration of immunosuppressive cells including tumor-associated macrophages (TAMs), plasmacytoid dendritic cells (pDCs), Th2 cells and T-regulatory cells (Tregs). This could facilitate the tumor immune escape and malignant progression of LUAD. Our findings provide new insights into the role of UBA3 in establishing an immunosuppressive tumor microenvironment by modulating nuclear factor kappa B (NF-kB) signaling and the neddylation pathway.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] The NEDD8-activating enzyme E1 UBA3 orchestrates the immunosuppressive microenvironment in lung adenocarcinoma via the NF-кB pathway
    Xiongzhi Lin
    Shuhan Yang
    Caichuan Zhou
    Chengcheng Ao
    Dongsheng Sun
    [J]. Medical Oncology, 40 (10)
  • [2] Inhibition of the NEDD8 Conjugation Pathway by shRNA to UBA3, the Subunit of the NEDD8-Activating Enzyme, Suppresses the Growth of Melanoma Cells
    Cheng, Fang
    Chen, Hao
    Zhang, Lei
    Li, Ruo-Hong
    Liu, Yi
    Sun, Jian-Fang
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (01) : 57 - 62
  • [3] Mutations In UBA3 Confer Resistance To The NEDD8-Activating Enzyme Inhibitor MLN4924 In Human Leukemic Cells
    Xu, G. Wei
    Toth, Julia I.
    da Silva, Sara R.
    Paiva, Stacey-Lynn
    Lukkarila, Julie L.
    Hurren, Rose
    Maclean, Neil
    Sukhai, Mahadeo A.
    Bhattacharjee, Rabindra N.
    Goard, Carolyn A.
    Medeiros, Bruno C.
    Gunning, Patrick T.
    Dhe-Paganon, Sirano
    Petroski, Matthew D.
    Schimmer, Aaron
    [J]. BLOOD, 2013, 122 (21)
  • [4] Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells
    Xu, G. Wei
    Toth, Julia I.
    da Silva, Sara R.
    Paiva, Stacey-Lynn
    Lukkarila, Julie L.
    Hurren, Rose
    Maclean, Neil
    Sukhai, Mahadeo A.
    Bhattacharjee, Rabindra N.
    Goard, Carolyn A.
    Gunning, Patrick T.
    Dhe-Paganon, Sirano
    Petroski, Matthew D.
    Schimmer, Aaron D.
    [J]. PLOS ONE, 2014, 9 (04):
  • [5] Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells (vol 9, e93530, 2014)
    Xu, G. W.
    Toth, J., I
    da Silva, S. R.
    Paiva, S-L
    Lukkarila, J. L.
    Medeiros, Bruno
    [J]. PLOS ONE, 2014, 9 (10):
  • [6] The Nedd8-Activating Enzyme Inhibitor MLN4924 Thwarts Microenvironment-Driven NF-κB Activation and Induces Apoptosis in Chronic Lymphocytic Leukemia B Cells
    Godbersen, J. Claire
    Humphries, Leigh Ann
    Danilova, Olga V.
    Kebbekus, Peter E.
    Brown, Jennifer R.
    Eastman, Alan
    Danilov, Alexey V.
    [J]. CLINICAL CANCER RESEARCH, 2014, 20 (06) : 1576 - 1589
  • [7] Targeting Microenvironment-Mediated NFκb Activation With MLN4924, An Inhibitor Of The Nedd8-Activating Enzyme, In Chronic Lymphocytic Leukemia B Cells
    Godbersen, Claire
    Eastman, Alan
    Brown, Jennifer R.
    Danilov, Alexey V.
    [J]. BLOOD, 2013, 122 (21)
  • [8] TAS4464, a Novel, Highly Potent NEDD8-Activating Enzyme Inhibitor Shows Antitumor Activity in Ibrutinib-Insensitive Mantle Cell Lymphoma Via Inactivation of the NF-κB Pathway
    Muraoka, Hiromi
    Yoshimura, Chihoko
    Tsuji, Shingo
    Hashimoto, Akihiro
    Nakagawa, Fumio
    Mizutani, Takashi
    Ohkubo, Shuichi
    Matsuo, Kenichi
    Utsugi, Teruhiro
    Iwasawa, Yoshikazu
    [J]. BLOOD, 2017, 130
  • [9] The Nedd8-Activating Enzyme Inhibitor MLN4924 Thwarts Microenvironment-Driven NF-κB Activation and Induces Apoptosis in Chronic Lymphocytic Leukemia B Cells (vol 20, pg 1576, 2014)
    Godbersen, J.
    Humphries, L.
    Danilova, O., V
    Kebbekus, P. E.
    Brown, J. R.
    Eastman, A.
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (16) : 4274 - 4274
  • [10] Integrin α6 overexpression promotes lymphangiogenesis and lymphatic metastasis via activating the NF-κB signaling pathway in lung adenocarcinoma
    Sijia Ren
    Jing Wang
    Anyi Xu
    Jiaqian Bao
    William C. Cho
    Jinrong Zhu
    Jianfei Shen
    [J]. Cellular Oncology, 2022, 45 : 57 - 67